Evidence map›Paper›PMID 33727607›Full record

ArticleScientific reports2021

Salvadora persica mediated synthesis of silver nanoparticles and their antimicrobial efficacy.

Hammad Arshad, Muhammad A Sami, Saima Sadaf, Umer Hassan

Abstract read
In one paragraph

Article in Scientific reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Review
  11. Phytofabrication of Silver Nanoparticles UsingInternational journal of molecular sciences · 2023
    Article
  12. Article
  13. Activity of Silver Nanoparticles againstInternational journal of molecular sciences · 2022
    Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Antioxidants (Basel, Switzerland) · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Hammad ArshadInstitute of Biochemistry and Biotechnology, University of the Punjab, Lahore, Pakistan.
Muhammad A SamiDepartment of Electrical and Computer Engineering, School of Engineering, Rutgers The State University of New Jersey, Piscataway, NJ, USA.
Saima SadafInstitute of Biochemistry and Biotechnology, University of the Punjab, Lahore, Pakistan.
Umer HassanDepartment of Electrical and Computer Engineering, School of Engineering, Rutgers The State University of New Jersey, Piscataway, NJ, USA. umer.hassan@rutgers.edu.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Silver nanoparticles (AgNPs) exhibit strong antimicrobial properties against many pathogens. Traditionally employed chemical methods for AgNPs synthesis are toxic for the environment. Here, we report a quicker, simpler, and environmentally benign process to synthesize AgNPs by using an aqueous 'root extract' of Salvadora persica (Sp) plant as a reducing agent. The synthesized Salvadora persica nano particles (SpNPs) showed significantly higher antimicrobial efficacy compared to earlier reported studies. We characterized SpNPs using UV-Vis spectroscopy, Fourier Transform Infrared Spectroscopy (FTIR), Transmission Electron Microscopy (TEM), Field Emission Scanning Electron Microscopy (FE-SEM), Dynamic Light Scattering (DLS) and X-ray powder diffraction (P-XRD). UV-Vis spectrum showed the highest absorbance at 420 nm. FTIR analysis depicts presence of bond stretching including OH- (3300 cm

Indexed as

Metal NanoparticlesSilverAnti-Infective AgentsDose-Response Relationship, DrugMicrobial Sensitivity TestsNanotechnologyPlant ExtractsSalvadoraceaeAnti-Infective AgentsPlant ExtractsSilver

Identifiers

PMID33727607
PMCPMC7966387

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.